NCT01137682 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 198
- units
- Participants
- groups
- description
- Supplied in blinded fashion as 20 and 40 mg powder in vials and 2 mL vehicle in ampoule (for reconstitution)
- id
- BG000
- title
- Pasireotide LAR 40 mg
- description
- Supplied in blinded fashion as 20 and 40 mg powder in vials and 2 mL vehicle in ampoule (for reconstitution)
- id
- BG001
- title
- Pasireotide LAR 60 mg
- description
- Open label octreotide LAR 30 mg or lanreotide ATG 120 mg supplied either locally or from designated depot. Administered intramuscular every 28 days
- id
- BG002
- title
- Control Arm (Octreotide or Lanreotide)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 182
- title
- <65 Years
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 16
- title
- ≥ 65 Years
- description
- CORE Period
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 111
- title
- Female
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 87
- title
- Male
- description
- CORE Period
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 161
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 15
- title
- Black
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 14
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- Native American
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- title
- Asian
- description
- CORE Period
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 198
- units
- Participants
- groups
- description
- Supplied in blinded fashion as 20 and 40 mg powder in vials and 2 mL vehicle in ampoule (for reconstitution)
- id
- BG000
- title
- Pasireotide LAR 40 mg
- description
- Supplied in blinded fashion as 20 and 40 mg powder in vials and 2 mL vehicle in ampoule (for reconstitution)
- id
- BG001
- title
- Pasireotide LAR 60 mg
- description
- Open label octreotide LAR 30 mg or lanreotide ATG 120 mg supplied either locally or from designated depot. Administered intramuscular every 28 days
- id
- BG002
- title
- Control Arm (Octreotide or Lanreotide)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 182
- title
- <65 Years
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 16
- title
- ≥ 65 Years
- description
- CORE Period
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 111
- title
- Female
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 87
- title
- Male
- description
- CORE Period
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 161
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 15
- title
- Black
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 14
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- Native American
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 4
- title
- Asian
- description
- CORE Period
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle